Fuxe K - Search Results

1

Neurochemical changes in the hippocampus of the brown Norway rat during aging.

Bhatnagar M, Cintra A, Chadi G, Lindberg J, Oitzl M, De Kloet ER, Möller A, Agnati LF, Fuxe K. Bhatnagar M, et al. Among authors: fuxe k. Neurobiol Aging. 1997 May-Jun;18(3):319-27. doi: 10.1016/s0197-4580(97)80314-4. Neurobiol Aging. 1997. PMID: 9263198

2

Evidence for an inhibitory dopaminergic and stimulatory noradrenergic hypothalamic influence of PMS-induced ovulation in the immature rat. I. Catecholamine turnover changes in relation to the critical period.

Löfström A, Agnati LF, Fuxe K. Löfström A, et al. Among authors: fuxe k. Neuroendocrinology. 1977;24(5-6):270-88. doi: 10.1159/000122716. Neuroendocrinology. 1977. PMID: 25395 No abstract available.

3

The effects of chronic treatment with the 5-hydroxytryptamine uptake blocker zimelidine on central 5-hydroxytryptamine mechanisms. Evidence for the induction of a low affinity binding site for 5-hydroxytryptamine.

Fuxe K, Ogren SO, Agnati LF. Fuxe K, et al. Neurosci Lett. 1979 Aug;13(3):307-12. doi: 10.1016/0304-3940(79)91511-8. Neurosci Lett. 1979. PMID: 530482

4

A method to determine dopamine levels and turnover rate in discrete dopamine nerve terminal systems by quantitative use of dopamine fluorescence obtained by Falck--Hillarp methodology.

Agnati LF, Andersson K, Wiesel F, Fuxe K. Agnati LF, et al. Among authors: fuxe k. J Neurosci Methods. 1979 Dec;1(4):365-73. doi: 10.1016/0165-0270(79)90025-6. J Neurosci Methods. 1979. PMID: 544977

5

Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.

Fuxe K, Fredholm BB, Agnati LF, Corrodi H. Fuxe K, et al. Brain Res. 1978 May 12;146(2):295-311. doi: 10.1016/0006-8993(78)90975-7. Brain Res. 1978. PMID: 647392

6

Studies on dopamine turnover in ovariectomized or hypophysectomized female rats. Effects of 17 beta-estradiol benzoate, ethynodioldiacetate and ovine prolactin.

Wiesel FA, Fuxe K, Hökfelt T, Agnati LF. Wiesel FA, et al. Among authors: fuxe k. Brain Res. 1978 Jun 16;148(2):399-411. doi: 10.1016/0006-8993(78)90728-x. Brain Res. 1978. PMID: 656940

7

Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.

Schwarcz R, Fuxe K, Agnati LF, Gustafsson JA. Schwarcz R, et al. Among authors: fuxe k. Life Sci. 1978 Aug 7;23(5):465-9. doi: 10.1016/0024-3205(78)90154-6. Life Sci. 1978. PMID: 692269 No abstract available.

8

The effect of mepiprazole on central monoamine neurons. Evidence for increased 5-hydroxytryptamine and dopamine receptor activity.

Fuxe K, Agnati LF, Ungerstedt U. Fuxe K, et al. Eur J Pharmacol. 1976 Jan;35(1):93-108. doi: 10.1016/0014-2999(76)90304-6. Eur J Pharmacol. 1976. PMID: 943291

9

Brain aging and neuronal plasticity.

Agnati LF, Benfenati F, Solfrini V, Biagini G, Fuxe K, Guidolin D, Carani C, Zini I. Agnati LF, et al. Among authors: fuxe k. Ann N Y Acad Sci. 1992 Dec 26;673:180-6. doi: 10.1111/j.1749-6632.1992.tb27451.x. Ann N Y Acad Sci. 1992. PMID: 1336643 Review. No abstract available.

10

Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.

Fuxe K, Janson AM, Rosén L, Finnman UB, Tanganelli S, Morari M, Goldstein M, Agnati LF. Fuxe K, et al. Exp Brain Res. 1992;88(1):117-30. doi: 10.1007/BF02259133. Exp Brain Res. 1992. PMID: 1347270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,336 results

Search Page

Filters